Got question for Dr Garg, M.D.? Click Here


Hip And Pelvis

"He cares for me and how my pain affects my life. " – Gregory D.


Experience Counts - Located in Jacksonville, Florida, we are the leader in Adult Stem Cell and Platelet-Rich Plasma (PRP) Procedures. We have performed these procedures for more than ten years with over 90 % results and ZERO side effects.

Top Stem Cell Center in the World: Unique Proven Clinical Protocols, over ten years of experience and hundreds of satisfied patients is why people from around the world come to us for their adult stem cell and Platelet-Rich Plasma Procedures. 

FIVE reasons you need to know before you decide. You will see why people around the world choose us over other Clinics.

Glaring Differences




Other Leading Stem Cell Clinics (including Regenexx, Cell surgical Networks and others)

1. Gene and Cellular tests to evaluate your stem cell functions.



2. Use BOTH Bone Marrow and Fat Stem Cells, along with PRP.



3. Process Your Stem Cells with safety and use no dangerous chemicals like collagenase.



4. Use Dynamic Ultrasound Guided Injections for Precision and safety (and NOT use X-Rays that can damage your cells).



5. Improve body functions with proprietary Hormones and Supplements, so you get the best possible clinical outcome.




At SmartChoice® we believe that cost should not be an obstacle to getting your quality of life back. We put these procedures within reach of most budgets.

Treatment costs less
than you might think.
Learn More

These treatments are already extensively used by people with sports injuries and orthopedic conditions, for faster recovery times and better results.

Over 95% success rate
for joint restoration.
Learn More

Last year, I successfully performed SmartChoice® Procedure on my son, Neil for a ligament injury near his shoulder. Yes, these procedures are safe.

Patient safety is our
number one priority
Learn More

At SmartChoice® Stem Cell Institute, we are leading non-surgical specialist for chronic hip and pelvis pain and injuries from :



If you have an injury to the hip joint, or if you have chronic hip pain due to osteoarthritis (also known as “degenerative joint disease” or “wear and tear” arthritis of the hip) or due to other medical conditions, you may be a candidate for our SmartChoice® Adult Stem Cell Procedures.

These SmartChoice® Joint Procedures may provide with simple, out-patient, natural alternatives to many patients so as to avoid the costly and risky orthopedic surgeries that also require long recovery periods.

Your hip is the joint where your thigh bone meets your pelvis bone. Hips are called ball-and-socket joints because the ball-like top of your thigh bone moves within a cup-like space in your pelvis. Your hips are very stable. When they are healthy, it takes great force to hurt them. However, playing sports, running, overuse or falling can all sometimes lead to hip injuries including strains, bursitis, tendonitis, arthritis, fractures and dislocations.

Certain diseases also lead to hip injuries or problems. Osteoarthritis can cause pain and limited motion. Osteoporosis of the hip causes weak bones that break easily. Both of these are common in older people. Treatment for hip disorders may include rest, medicines, physical therapy, or surgery, including hip replacement

Traditional options for patients suffering from the knee or hip injury, arthritis or pain include arthroscopic joint surgery, total knee or hip joint replacement. Besides the cost and the risks of those orthopedic surgeries, several months of rehabilitation is usually needed after the surgeries.

For many patients these intense orthopedic surgeries may not be an option due to their younger age especially considering the fact that we are living longer and more active lifestyle and the Joint Replacement may not last for more than 10 to 15 years. Also, the injuries may not be serious enough to require any surgery.

As alternatives to the knee and hip (and other joints) surgery or replacement, SmartChoice® Joint Procedures may help alleviate joint pain and the medical condition that causes it with a simple office injection procedure. We encourage the patients to walk the same day and most experience almost no downtime after our procedures whatsoever.

And if you are considering a knee, hip or other joint replacement, you might want to learn about how the adult stem cells and PRP procedures stack up against these risky Orthopedic surgeries.

Traditionally – a Total joint replacement of the hip or knee is often considered to be a accepted approach to treatment for patients suffering from significant arthritis or injury in their knee and hip joints. Over the years, due to aging baby-boomers and active lifestyle causing more sports injuries, these procedures have become more common. It has now become something that almost seems inevitable for us as we age.

But what about an alternative that could be just as successful as joint replacement and may be a better option for many of the patients before even considering joint replacement. And, all of this with significantly lower risk and cost.

When comparing two options - a treatment that involves simply an injection of your own natural cells in an outpatient setting may be significantly more attractive option for many patients than undergoing risky orthopedic surgery and replacing your entire joint with artificial material.

We play a key role in this cutting-edge stem cell medical field. While many types of stem cells are currently used in orthopedic healing, the most common are mesenchymal stem cells and hematopoietic stem cells to help regenerate tissue and rebuild cartilage, muscles, tendons and ligaments.

Because it is now possible to induce pluripotency in cells that have not come from embryos, the controversial use of embryonic stem cells has fallen on the way side and in the favor of the accessible cells found within the patient’s own body.

Patients coping with arthritis, sports injuries, tendon strains, sprained ligaments, muscle injuries and more, will be comforted to know that surgery is not the only option of treatment available to them. Faster healing as well as improved functionality both are possible with innovative, cutting- edge adult stem cell and PRP procedures.

 Stem Cells


1.     Complications of total hip replacement. Abbas K, Murtaza G, Umer M, Rashid H, Qadir I.   J Coll Physicians Surg Pak. 2012 Sep;22(9):575-8.
2. Revision rates for metal on metal hip joints are double that of other materials. BMJ 2011; 343

3.     Diagnosing and investigating adverse reactions in metal on metal hip implants.  BMJ 2011; 343 (Published 29 November 2011)
4.     Bone marrow aspirate and bone allograft to treat acetabular bone defects in revision total hip arthroplasty: preliminary report.  Vulcano E1, Murena L, Falvo DA, Baj A, Toniolo A, Cherubino P.   Eur Rev Med Pharmacol Sci. 2013 Aug;17(16):2240-9.
 5. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Kuroda R1, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, Ohgushi H, Wakitani S, Kurosaka M., Osteoarthritis Cartilage. 2007 Feb;15(2):226-31.

6.     Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. Gangji V1, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. J Bone Joint Surg Am. 2004 Jun;86-A(6):1153-60.
7.     Autologous bone marrow mesenchymal stem cells implantation for cartilage defects: two cases report. Kasemkijwattana C1, Hongeng S, Kesprayura S, Rungsinaporn V, Chaipinyo K, Chansiri K.   J Med Assoc Thai. 2011 Mar;94(3):395-400.
8.     Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Nejadnik H1, Hui JH, Feng Choong EP, Tai BC, Lee EH.  Am J Sports Med. 2010 Jun;38(6):1110-6.
9.     Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Qi Y, Feng G, Yan W.  Mol Biol Rep. 2012 May;39(5):5683-9.
10.  Developments in stem cells: implications for future joint replacements. Proc Maclaine SE, McNamara LE, Bennett AJ, Dalby MJ, Meek RM. Inst Mech Eng H. 2013 Mar;227(3):275-83.
11.  Current surgical options for articular cartilage repair. Peretti GM, Pozzi A, Ballis R, Deponti D, Pellacci F.   Acta Neurochir Suppl. 2011;108:213-9.
12.  Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis Qi Y, Feng G, Yan W.Mol Biol Rep. 2012 May;39(5):5683-9.
13. Roberts, Genever, McCaskie & De Bari; Prospects of stem cell therapy in osteoarthritis. Regen. Med. (2011) 6(3), 351–366).
 14. Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, Fornasari PM, Giannini S, Marcacci M. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011 Nov;27(11):1490-501.

15. Orozco L, Munar A, Soler R, Alberca M, Soler F, Huguet M, Sentís J, Sánchez A, García-Sancho J. Treatment of Knee Osteoarthritis with Autologous Mesenchymal Stem Cells: A Pilot Study. Transplantation. 2013 May 15.
 16. Dhinsa BS, Adesida AB. Current clinical therapies for cartilage repair, their limitation and the role of stem cells. Curr Stem Cell Res Ther. 2012 Mar;7(2):143-8.

17.Civinini R, Nistri L, Martini C, Redl B, Ristori G, Innocenti M. Growth factors in the treatment of early osteoarthritis. Clin Cases Miner Bone Metab. 2013 Jan;10(1):26-9.
18. Barry F, Murphy M. Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol. 2013 Jul 23. doi: 10.1038/nrrheum.2013.109.
 19. Autologous bone marrow concentrate: review and application of a novel intra-articular orthobiologic for cartilage disease.Sampson S1, Botto-van Bemden A, Aufiero D.  Phys Sportsmed. 2013 Sep;41(3):7-18.

 20.  Regenerative injection therapy with whole bone marrow aspirate for degenerative joint disease: a case series.Hauser RA1, Orlofsky A.   Clin Med Insights Arthritis Musculoskelet Disord. 2013 Sep 4;6:65-72. doi: 10.4137/CMAMD.S10951. eCollection 2013.
21.  Safety of autologous bone marrow aspiration concentrate transplantation: initial experiences in 101 patients. Hendrich C1, Franz E, Waertel G, Krebs R, Jäger M.  Orthop Rev (Pavia). 2009 Oct 10;1(2):e32
22. Stem cells and cartilage development: complexities of a simple tissue. Hollander AP, Dickinson SC, Kafienah W, Stem Cells 2010, 28:1992-1996. 
23. Cartilage tissue engineering: towards a biomaterial assisted mesenchymal stem cell therapy. Vinatier C, Bouffi C, Merceron C, Gordeladze J, Brondello JM, Jorgensen C, Weiss P, Guicheux J, Noel D.  Curr Stem Cell Res Ther 2009, 4:318-329.
24. REVIEW - Mesenchymal stem cells in arthritic diseases. Faye H Chen and Rocky S Tuan,  Arthritis Research & Therapy 2008, 10:223
25. Mesenchymal stem cells for cartilage repair in osteoarthritis. Pawan K Gupta1, Anjan K Das2, Anoop Chullikana1 and Anish S Majumdar. Stem Cell Research & Therapy 2012, 3:25
26.  Stem Cell Prolotherapy in Regenerative Medicine -Background, Theory and Protocols,  Donna D. Alderman, DO, Robert W. Alexander, MD, DMD, FICS, Gerald R. Harris, DO, Patrick C. Astourian, MS, PA-C, JOURNAL of PROLOTHERAPY | VOLUME 3, ISSUE 3 | AUGUST 2011
27. Chondrogenesis and cartilage tissue engineering: the longer road to technology development.  Mahmoudifar N1, Doran PM.  Trends Biotechnol. 2012 Mar;30(3):166-76.
28. Concise Review: The Clinical Application of Mesenchymal Stem Cells for Musculoskeletal Regeneration: Current Status and Perspectives
Andre F. Steinert, Lars Rackwitz, Fabian Gilbert, Ulrich Nöth and Rocky S. Tuan. Stem Cells Trans Med 2012, 1:237-247.

29. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.  Caplan AI ,  J Cell Physiol 2007, 213:341-347.
30. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Hass R, Kasper C, Bohm S, Jacobs R  - Cell Commun Signal 2011, 9:12
31.  Stem Cells and other innovative intra-articular therapies for osteoarthritis: What does the futurehold? Singh A Jasvinder. BMC Medicine 2012, 10:44
32. Marrow stromal cells as stem cells for nonhematopoietic tissues.  Prockop DJ. Science. 1997 Apr 4;276(5309):71-4.
33. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR . Science 1999,284:143-147

34. Stem cell therapy for cartilage regeneration in osteoarthritis.Koelling S1, Miosge N. Expert Opin Biol Ther. 2009 Nov;9(11):1399-405.
35. Intraarticular treatments for osteoarthritis: new perspectives. Chevalier X.Curr Drug Targets. 2010 May;11(5):546-60.
36.  Mesenchymal stem cell-based HLA-independent cell therapy for tissue engineering of bone and cartilage. Niemeyer P1, Krause U, Kasten P, Kreuz PC, Henle P, Südkam NP, Mehlhorn A.  Curr Stem Cell Res Ther. 2006 Jan;1(1):21-7.

37.  Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Nejadnik H1, Hui JH, Feng Choong EP, Tai BC, Lee EH.  Am J Sports Med. 2010 Jun;38(6):1110-6.

Back to Top